US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: Unveiling a 43.83% Potential Upside in the Biotech Sector

Genmab A/S (GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and robust collaborations. Headquartered in Copenhagen, Denmark, Genmab is renowned for developing..

Centene Corporation (CNC) Stock Analysis: A 34.93% Upside Potential in the Healthcare Sector

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare sector, focusing on managed care services for under-insured families and commercial organizations in the United States. With a..

Tenet Healthcare Corporation (THC) Stock Analysis: A 36% Growth Potential in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the healthcare sector, is catching the eye of investors with its substantial growth potential. With a market capitalization of $16.86 billion,..

Sanofi (SNY) Stock Analysis: Evaluating the 23.3% Potential Upside

Sanofi (SNY), a heavyweight in the healthcare sector and a stalwart in the global pharmaceutical industry, presents a compelling investment opportunity with a notable potential upside of 23.3%. Headquartered in..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring 16.47% Potential Upside in the Healthcare Diagnostics Sector

Labcorp Holdings Inc. (NYSE: LH) stands as a prominent player in the healthcare diagnostics and research industry with a market capitalization of $21.9 billion. Based in Burlington, North Carolina, Labcorp..

DexCom, Inc. (DXCM) Investor Outlook: Navigating a 39.96% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the medical devices industry, stands out with its focus on continuous glucose monitoring (CGM) systems. With a market capitalization of $24.28 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Eyeing a 76.98% Upside Potential Amidst Robust Revenue Growth

Tempus AI, Inc. (NASDAQ: TEM), a key player in the healthcare technology sector, is drawing significant attention from investors, thanks to its potential upside of 76.98% and remarkable revenue growth..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 66.93% Potential Upside

Doximity, Inc. (NYSE: DOCS), a leading digital platform for medical professionals, has been gaining attention in the healthcare sector. With its innovative approach to connecting healthcare providers, Doximity offers a..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Discovering Growth Opportunities with a Solid Dividend Yield

Takeda Pharmaceutical Company Limited (NYSE: TAK) presents itself as a promising investment opportunity, particularly for those interested in the healthcare sector. Based in Tokyo, Japan, Takeda is a global leader..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and 31.59% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the healthcare sector specializing in both specialty and generic drug manufacturing, continues to capture investor attention with its promising potential..

The Ensign Group, Inc. (ENSG) Stock Analysis: Navigating a 9.84% Potential Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the healthcare sector, is capturing the attention of investors with its robust potential upside of 9.84%. Based in San Juan..

Waters Corporation (WAT): Investor Outlook Shows 36% Potential Upside Amidst Strong Analyst Ratings

Waters Corporation (NYSE: WAT) stands out in the healthcare sector as a leading player within the diagnostics and research industry. Based in the United States, this $28.37 billion market cap..

HealthEquity, Inc. (HQY) Stock Analysis: A 35% Potential Upside in Healthcare Innovation

HealthEquity, Inc. (NASDAQ: HQY) stands as a notable player in the Health Information Services industry, offering a robust technology-enabled services platform focused on health savings accounts (HSAs) and various other..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Evaluating the 16.29% Potential Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a prominent player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $17.55 billion, this U.S.-based..

Ascendis Pharma A/S (ASND)

⚠️ No article content returned.

..

Penumbra, Inc. (PEN) Stock Analysis: Navigating Growth with a Potential 7.47% Upside

Penumbra, Inc. (NYSE: PEN), a prominent player in the medical devices sector, continues to capture investor attention with its innovative approaches and robust growth trajectory. The company, headquartered in Alameda,..

Humana Inc. (HUM) Stock Analysis: Exploring a Potential 25% Upside in Healthcare Plans

Humana Inc. (NYSE: HUM) stands as a prominent player in the healthcare sector, specifically within the healthcare plans industry. Based in the United States, Humana has carved out a significant..

Moderna, Inc. (MRNA) Investor Outlook: Navigating a Challenging Landscape with Strategic Collaborations and Diverse Pipeline

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has garnered significant investor attention due to its pioneering work in mRNA medicines. Despite a challenging financial landscape, the..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 24.83% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the healthcare sector, is capturing investor attention with a compelling potential upside of 24.83%. As a key distributor of healthcare products..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds